Future research will need to further explore the specific relationships between cuproptosis-related genes and other biomarkers such as EGFR, Kirsten Rat Sarcoma Viral Oncogene, and anaplastic lymphoma kinase to determine their combined roles in NSCLC prognosis and treatment. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.